Skip to content

Atrial Fibrillation Registry 2017

Monocentric, Randomized, Prospective Study to Compare Endocardiac Radio Frequency Ablation and Cryo Ablation of the Left Atrium During an Open Chest Mitral Valve Intervention

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05023590
Enrollment
50
Registered
2021-08-26
Start date
2017-02-22
Completion date
2023-07-31
Last updated
2021-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Mitral Valve Failure

Keywords

sinus rhythm, atrial fibrillation

Brief summary

Monocentric, prospective, randomized trial of cardiac surgical arrhythmia using endocardial radiofrequency atrial ablation compared with a cryo ablation system in the setting of cardiac surgery.

Detailed description

Regular, rhythmic monitoring (24-hour Holter ECG, 5 and 28 days, 3 and 6 months po) of patients after cardiac surgery on the mitral valve with atrial ablation for paroxysmal, persistent, and permanent atrial fibrillation with regard to the presence or stability of sinus rhythm.

Interventions

PROCEDUREablation of left atrium during mitral valve open chest intervention

open chest mitral valve surgery (reconstruction or replacement) with additional ablation of left atrium by cryo or radio frequency method

Sponsors

Herz- und Gefaesszentrum Bad Bevensen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

monocentric, 1:1 randomized (cryo ablation vs. radiofrequency ablation), open-label, parallel, registry

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years * Present, written informed consent from the patient * paroxysmal, persistent, or permanent atrial fibrillation not longer than 10 years according to guidelines (ACC, AHA, ESC) * planned cardiac surgery on the mitral valve * ECHO parameters : LA size a.p. ≤ 55mm

Exclusion criteria

* permanent atrial fibrillation longer than 10 years * ECHO parameters : LA size a.p. \> 55mm * pregnancy * life expectancy \< 12 months * lack of cognitive or mental capacity to participate in the study * Patients who are to be included in another clinical (interventional) study at the same time or who are already participating in such a study

Design outcomes

Primary

MeasureTime frameDescription
number of patients with stabil sinus rhythm 6 month after ablation6 month after index surgery / ablationnumber of patients with stabil sinus rhythm 6 month after ablation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026